United American Securities Inc. (D Edwards Lifesciences Corp Transaction History

United American Securities Inc. (D

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $131,024 - $202,500	-2,500 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $53,775 - $61,567	750 Added 42.86%	2,500 $583,000
Q3 2019 Nov 20, 2019	BUY	$61.55 - $75.43 $107,712 - $132,002	1,750 New	1,750 $385,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $324,685 - $375,188	-5,825 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $179,587 - $240,187	3,750 Added 180.72%	5,825 $1.11 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $96,300 - $118,150	2,075 New	2,075 $318,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of United American Securities Inc. (D, based on Form 13F filings with the SEC.

Stay updated on United American Securities Inc. (D with notifications on news.